Company Profile

Company Name BioMedCore, Inc.
Address Post Code 230-0046    IDEC Yokohama LVP Bld. 1-109,
75-1, Ono-cho, Tsurumi-ku, Yokohama-City, Kanagawa-Pref.,  Japan
TEL / FAX TEL : (+81)  45-501-1714      FAX : (+81)  45-501-1715
President and CEO Yuichiroh Satoh
Employee 10
Capital Yen 81,819,250
Established Dec. 2005



CEO Yuichiroh Satoh
Yuichiro Sato, DVM has served as our CEO since Dec. 2005.   From 2002 to 2005,  Dr. Sato was  assistant professor of Biomedicine,  Nagoya univ. school of medicine.   From 1996 to 2002, Dr. Sato was lecturer of bacteriology,  Hokkaido univ. school of medicine.   From 1978 to 1996, Dr. Sato was involved  in R&D of biomedicine.  Dr. Sato holds a DVM degree from Hokkaido Univ.
Director Norio Naruse
Norio Naruse has served as our board of director since Dec. 2005.  From 2003 to 2005, Mr. Naruse was managing director of Proteios Co.,,.Ltd.  From 1962 to 2003, Mr. Naruse performed various managing positions on regulatory dept., Pharmaceutical information, R&D of Pharmaceutical business unit in Toray, Inc.
Takuroh Wakabayashi
Takuro Wakabayashi has served as outside board director since Apr. 2011. Mr. Wakabayashi has served as CEO of Astech (Venture Capital) since 2001.
Takashi Kuramoto
Takashi Kuramoto has served as auditor since Sept. 2009.


Our Business


BioMedCore (BMC) will contribute to patients who are suffering from various disease, moreover support to people who want better life style with our  innovative Nano technologies.

  Our Business

 BMC provide one stop high quality service from formulation to commercial stage production of liposomal products with our LibMec® aseptic, in- line continuous innovative liposome manufacturing platform technology.
 BMC develop pipeline enabling to maximize clinical value with our own liposomal DDS technology collaborating with strategic partners. 
 BMC license liposome manufacturing related IP of LibMec® and its machinery to our clients.
 BMC supply liposomal supplement and cosmetic life style improving products from initial development to commercial production due to clients' contracted order.